SCHEMBL7746620

SCHEMBL7746620

CC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.57
FLT1 P17948 1/20 0.57
FLT4 P35916 1/20 0.57
ALOX15 P16050 1/20 0.42
ADORA3 P0DMS8 1/20 0.40
TOP2A P11388 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
BAZ1A Q9NRL2 1/20 0.38
ABL1 P00519 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
TP53 P04637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744668 0.90 KDR (0.69) KDRFLT1FLT4ALOX15NPC1
SCHEMBL7744087 0.89 KDR (0.46) KDRFLT1FLT4MEN1NPC1
SCHEMBL7739089 0.87 KDR (0.60) KDRFLT1FLT4ALOX15NPC1
SCHEMBL7746631 0.86 KDR (0.42) KDRFLT1FLT4ADORA3NPC1
SCHEMBL7746616 0.84 KDR (0.65) KDRFLT1FLT4ADORA3LMNA
SCHEMBL7739080 0.83 KDR (0.62) KDRFLT1FLT4ALOX15NPC1
SCHEMBL7744200 0.82 KDR (0.53) KDRFLT1FLT4ALOX15ADORA3
SCHEMBL7739016 0.82 KDR (0.56) KDRFLT1FLT4ALOX15MAPT
SCHEMBL7744664 0.82 KDR (0.55) KDRFLT1FLT4ALOX15MEN1
SCHEMBL7746642 0.82 KDR (0.55) KDRFLT1FLT4ALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed